Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Editorial · 29 Jul 2021 Research article · 2020 Initial Prostate Specific Antigen (PSA) Test can be used to Reduce the Burden Associated with Prostate Cancer Screening in High Risk Populations
Background: There is high mortality from prostate cancer in Nigeria. Lack of
Review article · 9 Aug 2016 Prostate health and male hormones
Andropause has a profound effect on prostate function, even though many mechanisms
Review article · 2011 An Eye on Breast and Prostate Cancers
Cancer is a class of diseases characterized by out-of-control cell
Article · 30 Apr 2024 Relationship between age, prostate size, and Prostate Specific Antigen (PSA) role in patients with Benign Prostatic Hyperplasia (BPH)
study. The standard investigations of BPH for each patient were: blood tests, urinalysis, prostate specific antigen testing, ultrasound and post-void residual volume. The same patients were observed for twenty…
Conference abstract · 2 Sep 2016 MicroRNA: A small non-coding RNA, an efficient biomarker for prostate cancer
biomarkers to identify in its early stage of development. Currently clinicians are using prostate specific antigen testing (PSA) and digital rectal examination (DRE) as early diagnostic tools for identifying prostate
Conference abstract · 10 Aug 2015 Evaluation of the clinical indications, adverse drug reactions, and finasteride use in patients with benign prostatic hyperplasia in Poland
intensification of urinary system symptoms. In addition, additional examinations were performed, including prostate-specific antigen test, urinary tract ultrasonography with evaluation of residual urine and prostate…
Conference abstract Evaluation of the clinical indications, adverse drug reactions, and finasteride use in patients with benign prostatic hyperplasia in Poland
intensification of urinary system symptoms. In addition, additional examinations were performed, including prostate-specific antigen test, urinary tract ultrasonography with evaluation of residual urine and prostate…
Conference abstract · 15 Jul 2013 Identification of miRNAs as specific biomarkers in prostate cancer diagnostics: A combined in silico and molecular approach
could lead to death. Current diagnostic tools include digital rectal examinations (DRE) (8), prostate specific antigen test (PSA)(11), biopsy(10) and ultra sound (9). All these diagnostic methods
Opinion · 30 Nov 2024 Prostate Cancer Screening: An In-Depth Guide
prostate cancer screening. It begins with a detailed analysis of the prostate-specific antigen (PSA) test, the digital rectal examination (DRE), and newer biomarkers, including genetic testing and imaging techniques…
Review article · 2015 Metabolic Complications of Androgen Deprivation Therapy for the Treatment of Prostate Cancer
Aim: Prostate cancer is the most commonly diagnosed cancer and second leading
Short communication · 2018 Clinical Approaches in Prostate Cancer Therapies
resistant to conventional chemotherapies, and targeted therapies are urgently needed. The PSA (Prostate-Specific Antigen) blood test has been used in various stages of prostate cancer management, including screening…
Mini review · 28 Feb 2023 Low Knowledge and Perception of Prostate Cancer Screening Among Men: Implications for Awareness and Screening Practices
Early detection of prostate cancer is essential for successful treatment outcomes. Screening tests, such as prostate-specific antigen (PSA) blood tests and digital rectal examinations (DRE), are commonly used
Conference abstract · 22 Jun 2015 Circulating tumor cells: A possible biomarker for diagnosis and therapies of prostate cancer
Drug Administration (FDA) approved the serum Prostate-Specific Antigen (PSA) test as a screening test to detect asymptomatic and earlystage prostate cancer. However, PSA is a relatively poor, nonspecific test…
Conference abstract · 26 Aug 2013 Prostate cancer and obesity
getting more importance aiming to early treatment with higher cure rates. The Prostate specific antigen (PSA) test is commonly used as a screening tool, as a part of the diagnostic ... rule out PCa as well as the…
Mini review · 30 Nov 2023 Prostate Cancer Diagnosis: The Significance of Digital Rectal Examinations
prostate cancer, discussing its effectiveness in conjunction with other diagnostic methods like prostate-specific antigen (PSA) testing and magnetic resonance imaging (MRI). We also address the limitations ... aspects…
Review article · 11 Aug 2016 What is multiparametric-MRI of the prostate and why do we need it?
Prostate cancer is the second leading cause of cancer death in men. Prostate-specific antigen (PSA) testing has led to an over-diagnosis of relatively indolent disease, which has been
Conference abstract · 27 Oct 2014 Testosterone supplementation and monitoring practices in HIV-infected men in a large multicenter US cohort: Results from CNICS
over 40 y who initiated testosterone, 33% had a pre-supplementation prostate specific antigen (PSA) test, and 12% had a PSA test 6 months after initiation. Conclusions: In a large
Article · 30 Jan 2023 PSA Test is the Use of MRI: Cost-Effective Method for Prostate Cancer Screening
cost-effective strategy, depending on various factors. PSA (prostate-specific antigen) is a blood test commonly used to screen for prostate cancer. However, PSA testing has limitations, including a high ... resonance…
Review article · 2015 The Ethical Dilemma Surrounding Prostate Specific Antigen (PSA) Screening
Food and Drug Administration approved testing for prostate cancer screening in 1994. Today over four decades have passed since the Prostate-Specific Antigen (PSA) was first discovered. Yet enormous uncertainty
Review article · 30 May 2018 Cancer-Devoted Liquid Biopsies and Applications to Prostate Cancer
facing two yet unsolved problems: first, at diagnosis, the prostate-specific antigen (PSA) blood test is not specific enough, which results in too much false positive detection; secondly
Research article · 6 Mar 2016 Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer patients and the significance of ROC curve in the diagnosis of prostate cancer bone metastases
patients that can cause bone pain and pathological fracture. This study tested serum levels of prostate specific antigen (PSA), alkaline phosphatase (ALP), bone sialoprotein (BSP), collagen type I pyridine crosslinking
Conference abstract · 30 Aug 2017 Reduced graphene-oxide based in-line impedimetric biosensor for detecting prostate cancer specific antigen
spectroscopy based rGO thin-films as transducer layers are tested out for label-free detection of Prostate Cancer Specific Antigen (PSA). This established biosensor exhibits ultra-sensitivity and announced sensing
Review article · 2013 Recent Developments in Prostate Cancer Screening Guidelines
utility of prostate cancer screening with prostate specific antigen. The purpose of this article is to evaluate the current status of prostate screening in light of the US Preventative Service ... risks associated with…

